Načítá se...

The inhibitor of cyclin-dependent kinases, olomoucine II, exhibits potent antiviral properties

BACKGROUND: Olomoucine II, the most recent derivative of roscovitine, is an exceptionally potent pharmacological inhibitor of cyclin-dependent kinase activities. Here, we report that olomoucine II is also an effective antiviral agent. METHODS: Antiviral activities of olomoucine II were tested on a r...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Holcakova, Jitka, Tomasec, Peter, Bugert, Joachim J, Wang, Eddie CY, Wilkinson, Gavin WG, Hrstka, Roman, Krystof, Vladimir, Strnad, Miroslav, Vojtesek, Borivoj
Médium: Artigo
Jazyk:Inglês
Vydáno: 2010
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2948526/
https://ncbi.nlm.nih.gov/pubmed/20054100
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3851/IMP1460
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!